These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 19513295)

  • 61. Patterns of Eye Movement Impairment Correlate with Regional Brain Atrophy in Neurodegenerative Parkinsonism.
    Vintonyak O; Gorges M; Müller HP; Pinkhardt EH; Ludolph AC; Huppertz HJ; Kassubek J
    Neurodegener Dis; 2017; 17(4-5):117-126. PubMed ID: 28268209
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Diffusion-weighted magnetic resonance imaging differentiates Parkinsonian variant of multiple-system atrophy from progressive supranuclear palsy.
    Paviour DC; Thornton JS; Lees AJ; Jäger HR
    Mov Disord; 2007 Jan; 22(1):68-74. PubMed ID: 17089396
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Diffusion-weighted imaging discriminates progressive supranuclear palsy from PD, but not from the parkinson variant of multiple system atrophy.
    Seppi K; Schocke MF; Esterhammer R; Kremser C; Brenneis C; Mueller J; Boesch S; Jaschke W; Poewe W; Wenning GK
    Neurology; 2003 Mar; 60(6):922-7. PubMed ID: 12654954
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Differences in [99mTc]TRODAT-1 SPECT binding to dopamine transporters in patients with multiple system atrophy and Parkinson's disease.
    Swanson RL; Newberg AB; Acton PD; Siderowf A; Wintering N; Alavi A; Mozley PD; Plossl K; Udeshi M; Hurtig H
    Eur J Nucl Med Mol Imaging; 2005 Mar; 32(3):302-7. PubMed ID: 15791439
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Discriminating among degenerative parkinsonisms using advanced (123)I-ioflupane SPECT analyses.
    Badoud S; Van De Ville D; Nicastro N; Garibotto V; Burkhard PR; Haller S
    Neuroimage Clin; 2016; 12():234-40. PubMed ID: 27489771
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Parkinson's disease or multiple system atrophy: potential separation by quantitative susceptibility mapping.
    Marxreiter F; Lambrecht V; Mennecke A; Hanspach J; Jukic J; Regensburger M; Herrler J; German A; Kassubek J; Grön G; Müller HP; Laun FB; Dörfler A; Winkler J; Schmidt MA
    Ther Adv Neurol Disord; 2023; 16():17562864221143834. PubMed ID: 36846471
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Differentiation of Parkinson's disease and multiple system atrophy in early disease stages by means of I-123-MIBG-SPECT.
    Druschky A; Hilz MJ; Platsch G; Radespiel-Tröger M; Druschky K; Kuwert T; Neundörfer B
    J Neurol Sci; 2000 Apr; 175(1):3-12. PubMed ID: 10785250
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Auditory brainstem responses in patients with autonomic failure with Parkinson's disease and multiple system atrophy.
    Kodama Y; Ieda T; Hirayama M; Koike Y; Ito H; Sobue G
    J Auton Nerv Syst; 1999 Sep; 77(2-3):184-9. PubMed ID: 10580301
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Differentiation of idiopathic Parkinson's disease, multiple system atrophy, progressive supranuclear palsy, and healthy controls using magnetization transfer imaging.
    Eckert T; Sailer M; Kaufmann J; Schrader C; Peschel T; Bodammer N; Heinze HJ; Schoenfeld MA
    Neuroimage; 2004 Jan; 21(1):229-35. PubMed ID: 14741660
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Comparison of magnetic resonance imaging in subtypes of multiple system atrophy.
    Lee EA; Cho HI; Kim SS; Lee WY
    Parkinsonism Relat Disord; 2004 Aug; 10(6):363-8. PubMed ID: 15261878
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Iodine 123-labeled meta-iodobenzylguanidine myocardial scintigraphy in the cases of idiopathic Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy].
    Yoshita M; Hayashi M; Hirai S
    Rinsho Shinkeigaku; 1997 Jun; 37(6):476-82. PubMed ID: 9366173
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Semiautomated Algorithm for the Diagnosis of Multiple System Atrophy With Predominant Parkinsonism.
    Lee WW; Kim HJ; Lee HJ; Kim HB; Park KS; Sohn CH; Jeon B
    J Mov Disord; 2022 Sep; 15(3):232-240. PubMed ID: 35880384
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Co-registration Analysis of Fluorodopa and Fluorodeoxyglucose Positron Emission Tomography for Differentiating Multiple System Atrophy Parkinsonism Type From Parkinson's Disease.
    Xian WB; Shi XC; Luo GH; Yi C; Zhang XS; Pei Z
    Front Aging Neurosci; 2021; 13():648531. PubMed ID: 33958998
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Automated Categorization of Parkinsonian Syndromes Using Magnetic Resonance Imaging in a Clinical Setting.
    Chougar L; Faouzi J; Pyatigorskaya N; Yahia-Cherif L; Gaurav R; Biondetti E; Villotte M; Valabrègue R; Corvol JC; Brice A; Mariani LL; Cormier F; Vidailhet M; Dupont G; Piot I; Grabli D; Payan C; Colliot O; Degos B; Lehéricy S
    Mov Disord; 2021 Feb; 36(2):460-470. PubMed ID: 33137232
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Different loss of dopamine transporter according to subtype of multiple system atrophy.
    Kim HW; Kim JS; Oh M; Oh JS; Lee SJ; Oh SJ; Chung SJ; Lee CS
    Eur J Nucl Med Mol Imaging; 2016 Mar; 43(3):517-25. PubMed ID: 26384682
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Voxel-wise analysis of [123I]beta-CIT SPECT differentiates the Parkinson variant of multiple system atrophy from idiopathic Parkinson's disease.
    Scherfler C; Seppi K; Donnemiller E; Goebel G; Brenneis C; Virgolini I; Wenning GK; Poewe W
    Brain; 2005 Jul; 128(Pt 7):1605-12. PubMed ID: 15817519
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Supine hypertension in Parkinson's disease and multiple system atrophy.
    Fanciulli A; Göbel G; Ndayisaba JP; Granata R; Duerr S; Strano S; Colosimo C; Poewe W; Pontieri FE; Wenning GK
    Clin Auton Res; 2016 Apr; 26(2):97-105. PubMed ID: 26801189
    [TBL] [Abstract][Full Text] [Related]  

  • 78. An magnetic resonance imaging T2*-weighted sequence at short echo time to detect putaminal hypointensity in Parkinsonisms.
    Arabia G; Morelli M; Paglionico S; Novellino F; Salsone M; Giofrè L; Torchia G; Nicoletti G; Messina D; Condino F; Lanza P; Gallo O; Quattrone A
    Mov Disord; 2010 Dec; 25(16):2728-34. PubMed ID: 20925073
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Differing patterns of striatal 18F-dopa uptake in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy.
    Brooks DJ; Ibanez V; Sawle GV; Quinn N; Lees AJ; Mathias CJ; Bannister R; Marsden CD; Frackowiak RS
    Ann Neurol; 1990 Oct; 28(4):547-55. PubMed ID: 2132742
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Alterations in the levels of iron, ferritin and other trace metals in Parkinson's disease and other neurodegenerative diseases affecting the basal ganglia.
    Dexter DT; Carayon A; Javoy-Agid F; Agid Y; Wells FR; Daniel SE; Lees AJ; Jenner P; Marsden CD
    Brain; 1991 Aug; 114 ( Pt 4)():1953-75. PubMed ID: 1832073
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.